Assertio Holdings, Inc. (ASRT)
NASDAQ: ASRT · IEX Real-Time Price · USD
1.505
+0.035 (2.38%)
At close: Jul 26, 2024, 4:00 PM
1.519
+0.014 (0.93%)
After-hours: Jul 26, 2024, 7:08 PM EDT
Assertio Holdings Revenue
Assertio Holdings had revenue of $32.45M in the quarter ending March 31, 2024, a decrease of -23.59%. This brings the company's revenue in the last twelve months to $142.05M, down -12.40% year-over-year. In the year 2023, Assertio Holdings had annual revenue of $152.07M, down -2.67%.
Revenue (ttm)
$142.05M
Revenue Growth
-12.40%
P/S Ratio
1.01
Revenue / Employee
$2,680,208
Employees
53
Market Cap
143.16M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 152.07M | -4.17M | -2.67% |
Dec 31, 2022 | 156.23M | 45.22M | 40.73% |
Dec 31, 2021 | 111.01M | 2.94M | 2.72% |
Dec 31, 2020 | 108.08M | -121.45M | -52.91% |
Dec 31, 2019 | 229.53M | -26.54M | -10.36% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
InfuSystem Holdings | 127.41M |
Harvard Bioscience | 106.79M |
Capricor Therapeutics | 27.10M |
Zomedica | 25.97M |
Myomo | 19.55M |
Cellectis | 12.13M |
ASRT News
- 2 days ago - Assertio Holdings, Inc. to Report Second Quarter 2024 Financial Results on August 7, 2024 - GlobeNewsWire
- 2 days ago - Buxton Helmsley Issues Letter to the Board of Directors of Assertio Holdings, Inc. - Business Wire
- 17 days ago - Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 22 days ago - ASSERTIO ALERT: Bragar Eagel & Squire, P.C. is Investigating Assertio Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewsWire
- 7 weeks ago - Assertio to Participate in the Sidoti Small Cap Conference on June 12, 2024 - GlobeNewsWire
- 2 months ago - Assertio to Participate in Benchmark Healthcare Conference on May 21-22 - GlobeNewsWire
- 2 months ago - BUXTON HELMSLEY RELEASES LETTER FROM CERTIFIED FRAUD EXAMINER ATTESTING TO DISCLOSURE FAILURES AND DEFICIENCIES BY ASSERTIO HOLDINGS BOARD OF DIRECTORS - PRNewsWire
- 2 months ago - Assertio to Participate in AGP Healthcare Conference on May 21 - GlobeNewsWire